Hypoxia-inducible factor
Hypoxia-inducible factors (HIFs) are transcription factors that respond to decreases in available oxygen in the cellular environment, or hypoxia.
Overview[edit]
Hypoxia-inducible factors are a family of heterodimeric transcription factors that are most commonly activated in response to low oxygen conditions, or hypoxia. They play an essential role in the body's response to hypoxia by activating the transcription of many genes including those involved in energy metabolism, angiogenesis, apoptosis, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia.
Structure[edit]
HIFs are heterodimers consisting of an alpha subunit and a beta subunit. The alpha subunit is unstable under normoxic conditions and is constantly synthesized and degraded. However, under hypoxic conditions, the alpha subunit is stabilized, dimerizes with the beta subunit and is translocated to the nucleus where it binds to hypoxia response elements (HREs) in the promoter region of target genes.
Function[edit]
The primary function of HIFs is to regulate oxygen homeostasis in both unicellular and multicellular organisms. They are involved in the regulation of a variety of genes that play crucial roles in adaptation to low oxygen conditions. These include genes involved in angiogenesis, erythropoiesis, cell cycle, apoptosis, and glucose metabolism.
Clinical significance[edit]
HIFs have been implicated in the pathophysiology of various diseases including cancer, ischemic diseases, and chronic lung diseases. They are also involved in the pathogenesis of chronic kidney disease and have been implicated in the progression of renal fibrosis.
See also[edit]
References[edit]
Hypoxia-inducible factor[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian